Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.74B |
| 2 |
Apple
AAPL
|
+$1.44B |
| 3 |
RAI
Reynolds American Inc
RAI
|
+$884M |
| 4 |
Microsoft
MSFT
|
+$491M |
| 5 |
Blackstone
BX
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.5B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.87B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.58B |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$859M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.19% |
| 2 | Financials | 9.14% |
| 3 | Technology | 8.77% |
| 4 | Communication Services | 7.62% |
| 5 | Consumer Discretionary | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCB
2951
DELISTED
FCB Financial Holdings, Inc.
FCB
| $3.46M | ﹤0.01% |
96,787
+86,496
| +841% | +$3.09M |
|
2952
MannKind Corp
MNKD
$1.32B
| $3.46M | ﹤0.01% |
477,784
+92,265
| +24% | +$1.13M |
|
2953
Fulton Financial
FULT
$4.64B
| $3.46M | ﹤0.01% |
265,810
+184,713
| +228% | +$2.48M |
|
2954
Groupon
GRPN
$1.02B
| $3.45M | ﹤0.01% |
56,175
-37,903
| -40% | -$2.44M |
|
2955
Repligen
RGEN
$9.25B
| $3.45M | ﹤0.01% |
121,884
-40,190
| -25% | -$1.16M |
|
2956
El Pollo Loco
LOCO
$462M
| $3.45M | ﹤0.01% |
272,860
-14,234
| -5% | -$169K |
|
2957
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.17B
| $3.45M | ﹤0.01% |
137,531
-93,414
| -40% | -$2.38M |
|
2958
AptarGroup
ATR
$8.61B
| $3.44M | ﹤0.01% |
47,371
-7,700
| -14% | -$556K |
|
|
PHH
2959
DELISTED
PHH Corporation
PHH
| $3.44M | ﹤0.01% |
212,491
-92,669
| -30% | -$1.43M |
|
2960
iShares MSCI Sweden ETF
EWD
$595M
| $3.44M | ﹤0.01% |
117,956
+9,538
| +9% | +$285K |
|
2961
Natural Health Trends
NHTC
$14.8M
| $3.44M | ﹤0.01% |
102,634
+59,868
| +140% | +$2.64M |
|
2962
Ultragenyx Pharmaceutical
RARE
$2.55B
| $3.44M | ﹤0.01% |
30,681
-6,794
| -18% | -$679K |
|
|
CEO
2963
DELISTED
CNOOC Limited
CEO
| $3.44M | ﹤0.01% |
32,953
-1,697
| -5% | -$188K |
|
2964
Digi International
DGII
$3.1B
| $3.44M | ﹤0.01% |
301,993
+66,203
| +28% | +$812K |
|
|
FAV
2965
DELISTED
FIRST TRUST DIVIDEND AND INCOME FD COM
FAV
| $3.43M | ﹤0.01% |
404,955
-109,415
| -21% | -$901K |
|
2966
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$257M
| $3.42M | ﹤0.01% |
147,495
+19,080
| +15% | +$429K |
|
2967
PENN Entertainment
PENN
$2.71B
| $3.42M | ﹤0.01% |
213,459
-136,708
| -39% | -$2.3M |
|
|
ZVO
2968
DELISTED
Zovio Inc. Common Stock
ZVO
| $3.42M | ﹤0.01% |
449,199
-126,634
| -22% | -$1.01M |
|
|
WBC
2969
DELISTED
WABCO HOLDINGS INC.
WBC
| $3.41M | ﹤0.01% |
33,381
-3,634
| -10% | -$387K |
|
|
DXJF
2970
DELISTED
WisdomTree Japan Hedged Financials Fund
DXJF
| $3.41M | ﹤0.01% |
131,018
-184,500
| -58% | -$5.01M |
|
|
ETO
2971
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$520M
| $3.4M | ﹤0.01% |
159,300
+2,156
| +1% | +$47.6K |
|
2972
Haemonetics
HAE
$4B
| $3.39M | ﹤0.01% |
105,217
-109,923
| -51% | -$3.57M |
|
|
CBB
2973
DELISTED
Cincinnati Bell Inc.
CBB
| $3.39M | ﹤0.01% |
188,184
+23,122
| +14% | +$418K |
|
|
OMED
2974
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $3.39M | ﹤0.01% |
150,262
+40,178
| +36% | +$823K |
|
|
CNCE
2975
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.39M | ﹤0.01% |
178,502
-191,724
| -52% | -$4.17M |
|
Similar funds
Morgan Stanley's Q4 2015 Portfolio in Review
As of Q4 2015, Morgan Stanley held 7,145 positions worth $276B, up 2.1% from $271B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Morgan Stanley's Q4 2015 filing shows 406 new, 2,973 increased, 3,194 reduced and 176 closed positions. Its largest new stake was Alphabet (Google) Class A: 47,024,460 shares worth $1.83B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.5B.
By sector, the portfolio is most concentrated in Healthcare at 9.2% of assets, up from 9.1% a quarter earlier, followed by Financials and Technology.
- Morgan Stanley's largest Q4 2015 buy was Alphabet (Google) Class A: 47,024,460 shares worth $1.83B.
- Morgan Stanley added most to Apple in Q4 2015, an estimated $1.44B increase.
- Morgan Stanley's biggest Q4 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.5B.
- Morgan Stanley fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 13% of its $276B portfolio in Q4 2015.
- Morgan Stanley opened 406 new positions and closed 176 in Q4 2015.
- Morgan Stanley's portfolio value rose 2.1% quarter-over-quarter to $276B.
Based on Morgan Stanley's 13F filing for Q4 2015, filed 9 Feb 2016.